Laddar...
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature
Breast tumours positive for her2 (human epidermal growth factor receptor 2) represent approximately 20% of all breast cancer cases and are associated with an aggressive natural history. The advent of targeted anti-her2 therapies has dramatically improved disease control and survival in patients with...
Sparad:
| I publikationen: | Curr Oncol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Multimed Inc.
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381788/ https://ncbi.nlm.nih.gov/pubmed/25848336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2363 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|